These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 17116980

  • 1. New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.
    Wang Y, Takao Y, Harada M, Yutani S, Ide T, Sata M, Itoh K, Yamada A.
    Microbiol Immunol; 2006; 50(11):857-65. PubMed ID: 17116980
    [Abstract] [Full Text] [Related]

  • 2. Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
    Wang Y, Takao Y, Harada M, Komatsu N, Ono T, Sata M, Itoh K, Yamada A.
    Cell Immunol; 2006 May; 241(1):38-46. PubMed ID: 16963008
    [Abstract] [Full Text] [Related]

  • 3. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.
    Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, Ching WM, Grakoui A, Rice CM, Kurokohchi K.
    J Virol; 1995 Apr; 69(4):2462-70. PubMed ID: 7884894
    [Abstract] [Full Text] [Related]

  • 4. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
    Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B, Fowler P, Houghton M, Chisari FV.
    J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734
    [Abstract] [Full Text] [Related]

  • 5. DCs pulsed with novel HLA-A2-restricted CTL epitopes against hepatitis C virus induced a broadly reactive anti-HCV-specific T lymphocyte response.
    Guo Z, Zhang H, Rao H, Jiang D, Cong X, Feng B, Wang J, Wei L, Chen H.
    PLoS One; 2012 Feb; 7(6):e38390. PubMed ID: 22701633
    [Abstract] [Full Text] [Related]

  • 6. Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes.
    Sarobe P, Huarte E, Lasarte JJ, López-Díaz de Cerio A, García N, Borrás-Cuesta F, Prieto J.
    J Hepatol; 2001 Feb; 34(2):321-9. PubMed ID: 11281563
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.
    Kurokohchi K, Akatsuka T, Pendleton CD, Takamizawa A, Nishioka M, Battegay M, Feinstone SM, Berzofsky JA.
    J Virol; 1996 Jan; 70(1):232-40. PubMed ID: 8523531
    [Abstract] [Full Text] [Related]

  • 10. Immunogenic variation between multiple HLA-A*0201-restricted, Hepatitis C Virus-derived epitopes for cytotoxic T lymphocytes.
    Ohno S, Moriya O, Yoshimoto T, Hayashi H, Akatsuka T, Matsui M.
    Viral Immunol; 2006 Jan; 19(3):458-67. PubMed ID: 16987064
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A new epitope peptide derived from hepatitis C virus 1b possessing the capacity to induce cytotoxic T-lymphocytes in HCV1b-infected patients with HLA-A11, -A31, and -A33.
    Matsueda S, Yamada A, Takao Y, Tamura M, Komatsu N, Yutani S, Ide T, Sata M, Itoh K.
    Cancer Immunol Immunother; 2007 Sep; 56(9):1359-66. PubMed ID: 17265020
    [Abstract] [Full Text] [Related]

  • 13. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM, Gruener NH, Southwood S, Sidney J, Pape GR, Chisari FV, Sette A.
    J Immunol; 1999 Jan 15; 162(2):1156-64. PubMed ID: 9916747
    [Abstract] [Full Text] [Related]

  • 14. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
    Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, Engelhard VH, Feinstone SM, Berzofsky JA.
    J Immunol; 1995 Mar 15; 154(6):2733-42. PubMed ID: 7533182
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Characterization of cross-reactive CD8+ T-cell recognition of HLA-A2-restricted HIV-Gag (SLYNTVATL) and HCV-NS5b (ALYDVVSKL) epitopes in individuals infected with human immunodeficiency and hepatitis C viruses.
    Vali B, Tohn R, Cohen MJ, Sakhdari A, Sheth PM, Yue FY, Wong D, Kovacs C, Kaul R, Ostrowski MA.
    J Virol; 2011 Jan 15; 85(1):254-63. PubMed ID: 20980521
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Identification of a novel HLA-A2-restrictive CTL epitope of an ovary cancer-associated antigen OVA66].
    Jin S, Wang Y, Wang SJ, Zhang HZ, Li MX, Chen Y, Ge HL.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2005 Mar 15; 21(2):233-6, 242. PubMed ID: 15766414
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.